Opens in a new tab
Get in Touch - We're here to help
The Forbury Clinic

Prostate Cancer Screening in London

Personalised prostate cancer screening brings together established assessments, including PSA testing and MRI where appropriate, with genetic risk assessment. This helps build a clearer picture of your prostate health and supports a screening plan based on your individual risk.

Our service is consultant-led and delivered in partnership with Antegenes, using a simple saliva test to assess inherited risk before symptoms develop.

  • From age 40

    Personalised to your risk
    PSA, MRI and genetic risk
    Simple at-home saliva test
    In partnership with Antegenes

A more personalised approach to prostate cancer screening

Prostate cancer is the most common cancer in men in the UK, with around 57,900 men diagnosed each year. It often causes no symptoms in its early stages, which is why some men choose to understand their risk before they notice any changes.

A PSA, or prostate-specific antigen, blood test is an important part of prostate health assessment. However, PSA levels can be affected by several factors and may not always give a complete picture on their own.

Our screening service adds genetic risk assessment to established prostate checks. Genetic factors can influence a man’s lifetime risk of developing prostate cancer, even where there is no known family history.

In partnership with Antegenes, we use a polygenic risk score to assess inherited risk. This does not replace PSA testing, MRI or clinical assessment. It adds further information that can help your consultant advise when screening should begin, how often it may be repeated and whether further investigation is appropriate.

Three strands, one clearer picture

What the assessment looks at

Prostate cancer screening combines established tests with genetic insight, helping make screening more individual to you.

PSA blood test

A blood test that measures prostate-specific antigen. It can provide useful information about prostate health and is interpreted alongside other findings.

MRI where appropriate

A detailed MRI scan can provide further information about the prostate, identify areas that may need closer assessment and help guide whether additional tests are needed.

Genetic risk score

An Antegenes polygenic risk score assesses inherited risk using common genetic variants linked with prostate cancer.

What is a polygenic risk score?
A polygenic risk score, often shortened to PRS, looks at the combined effect of a large number of common genetic variants associated with prostate cancer risk. Each individual variant has only a small effect, but together they can provide a more detailed estimate of inherited risk. This is different from single-gene testing, which looks for rarer inherited changes in genes such as BRCA1 or BRCA2. A polygenic risk score does not diagnose prostate cancer and does not replace other forms of genetic testing where there is a strong family history of cancer.

The test uses a saliva sample and only needs to be carried out once, as your genetic makeup does not change. The result is considered alongside factors such as your age, ethnicity and family history, helping your consultant discuss a screening approach tailored to you.

Who prostate cancer screening may suit

Personalised prostate cancer screening may be worth considering if you:

  • Are a man aged 40 or over
  • Have a father or brother who has had prostate cancer
  • Are of Black or Afro-Caribbean heritage
  • Have concerns about your inherited risk
  • Would like more information than a PSA test alone can provide
  • Want to take a proactive approach to prostate health

What to expect

  1. Arrange your test and provide a sample
    Following your enquiry, a saliva collection kit can be sent to your home or arranged during a clinic appointment. You provide the sample and return it securely for analysis.
  2. Laboratory analysis
    Your sample is analysed to assess genetic markers associated with prostate cancer risk.
  3. Results and consultant plan
    A detailed report is prepared following laboratory analysis. Your consultant will explain what the results mean in the context of your prostate health and agree the appropriate next steps with you.

Why choose The Forbury Clinic for Prostate Cancer Screening in London?

Why The Forbury Clinic
1

A more complete understanding of risk

Genetic risk assessment can add information that PSA testing alone cannot provide.

2

Screening tailored to you

Your consultant considers your genetic result alongside your age, ethnicity, family history and prostate health.

3

A simple test with lifelong relevance

The genetic assessment uses a non-invasive saliva sample and only needs to be completed once.

4

Consultant-led care in London

Your results are interpreted by a specialist, who will turn them into clear and practical advice at The Forbury Clinic, 45 Queen Anne St, London W1G 9JF.

Putting your results to work

How genetic risk assessment can guide screening

Genetic risk assessment does not replace PSA testing or MRI. It can help make decisions about screening more personal, so that your care is neither more intensive nor less frequent than your individual risk suggests.

If your risk is higher
Your consultant may recommend earlier or more regular PSA testing, MRI or other appropriate assessment.

If your risk is lower
Your consultant may advise a less frequent review schedule, based on the full picture of your health and risk factors.

A clear plan either way
You will have a clearer understanding of your inherited risk and a practical plan for looking after your prostate health over time.

Frequently asked questions

Do I need to visit the clinic for the test?

Not necessarily. The saliva sample can usually be collected at home. You may prefer to attend the clinic, or your consultant may recommend an appointment to discuss your results and next steps.

Is this the same as BRCA genetic testing?

No. This test uses common genetic variants to estimate overall inherited risk. Testing for rarer inherited gene changes, such as BRCA1 and BRCA2, is separate and may be appropriate where there is a strong family history of prostate or related cancers.

Is the genetic test diagnostic?

No. It does not detect prostate cancer. It estimates inherited risk and can help guide decisions about when and how often prostate health checks should be considered.

Can I have the test if my PSA is normal?

Yes. Genetic risk assessment may provide useful information even if your PSA result is within the expected range.

How long do results take?

Your consultant will explain the expected timeframe when your test is arranged. Once the report is available, they will discuss what it means and whether any further assessment is appropriate.

What age should I consider prostate cancer screening?

Many men begin considering prostate health assessment from around age 40. Earlier discussion may be appropriate if you have a close family history of prostate cancer or other factors associated with higher risk.

Reviewed by Mr. Steve Foley
Mr. Foley is a Consultant Urological Surgeon with a focus on female urology and male incontinence.
Last reviewed: 11 Sep 2026.

Understand your prostate cancer risk

Book an Appointment

Whether you want reassurance or are concerned about your personal or family history, our consultant-led screening service can help you understand your risk and plan the appropriate next steps.

  • Appointment
    Book a consultation
  • Reception
    0118 920 7055
  • Location

    The Forbury Clinic London, 45 Queen Anne St, London, W1G 9J

Treatment suitability is determined following consultation with a specialist. Individual results and recommendations vary.
Contact Form